Diffuse Large B-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Diffuse Large B-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2025-06-18FDA Approved: MONJUVI — Supplemental Application (Incyte Corporation)
FDA approved a supplemental application for MONJUVI (tafasitamab-cxix) from Incyte, resulting in changes to the product labeling.